Status:
COMPLETED
Evaluation of the Implementation of a Quality Improvement Program Through Morbidity and Mortality Reviews
Lead Sponsor:
Moroccan Society of Surgery
Conditions:
Quality Improvement
Eligibility:
All Genders
Brief Summary
Morbidity and mortality reviews represent an opportunity to discuss adverse events and healthcare issues. Aim is to report the first experience of implementing a standardized procedure of morbidity an...
Detailed Description
From July 2019 to December 2019, members of the surgical and intensive care unit departments designed and implemented a regular procedure of morbidity and mortality reviews. Cases of severe postoperat...
Eligibility Criteria
Inclusion
- severe adverse events defined as postoperative morbidity \> 3a according to the Clavien Dindo grading system
- within the first 90 postoperative days of surgery
- Cases discussed in a morbidity and mortality review
Exclusion
- Cases not discussed in a morbidity mortality review
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2020
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT05286411
Start Date
January 1 2019
End Date
January 31 2020
Last Update
April 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Oncology
Rabat, Morocco, 10090